{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:36:53Z","timestamp":1791175013187,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.08.102","type":"journal-article","created":{"date-parts":[[2009,10,17]],"date-time":"2009-10-17T08:27:11Z","timestamp":1255768031000},"page":"D28-D32","source":"Crossref","is-referenced-by-count":68,"special_numbering":"S4","title":["Advances in the development of next-generation anthrax vaccines"],"prefix":"10.1016","volume":"27","author":[{"given":"Arthur M.","family":"Friedlander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.08.102_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/infdis\/80.1.28","article-title":"Studies on infection with Bacillus anthracis III. Chemical and immunological properties of the protective antigen in crude extracts of skin lesions of B. anthracis","volume":"80","author":"Watson","year":"1947","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.08.102_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142728","article-title":"Anthrax toxin: receptor binding, internalization, pore formation, and translocation","volume":"76","author":"Young","year":"2007","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.vaccine.2009.08.102_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.it.2006.07.002","article-title":"Anthrax toxins: a paradigm of bacterial immune suppression","volume":"27","author":"Baldari","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib4","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0264-410X(97)00132-1","article-title":"Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection","volume":"15","author":"Pomerantsev","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/IAI.74.1.794-797.2006","article-title":"Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen","volume":"74","author":"Peachman","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib6","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib7","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib8","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/0264-410X(95)00139-R","article-title":"Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs","volume":"13","author":"Ivins","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib9","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1128\/IAI.74.1.394-398.2006","article-title":"Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits","volume":"74","author":"Weiss","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib12","series-title":"The anthrax vaccine: Is it safe? Does it work?","first-page":"180","author":"Committee to Assess the Safety Efficacy of the Anthrax Vaccine MFA","year":"2002"},{"key":"10.1016\/j.vaccine.2009.08.102_bib13","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1365-2672.2007.03391.x","article-title":"A study of the physiology of Bacillus anthracis Sterne during manufacture of the UK acellular anthrax vaccine","volume":"103","author":"Charlton","year":"2007","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib14","unstructured":"BioThrax (Anthrax Vaccine Adsorbed) Emergent BioSolutions. www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm124496.pdf. 2008;1\u201316."},{"key":"10.1016\/j.vaccine.2009.08.102_bib15","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.300.13.1532","article-title":"Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months","volume":"300","author":"Marano","year":"2008","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2009.08.102_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00189414","article-title":"Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"177","author":"Turnbull","year":"1988","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/CVI.00321-07","article-title":"Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor","volume":"15","author":"Taft","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib18","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1016\/j.vaccine.2004.04.036","article-title":"Characterisation of adsorbed anthrax vaccine by two-dimensional gel electrophoresis","volume":"22","author":"Whiting","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib19","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1128\/IAI.73.9.5685-5696.2005","article-title":"Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation","volume":"73","author":"Kudva","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib20","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine","volume":"52","author":"Brachman","year":"1962","journal-title":"Am J Pub Health"},{"key":"10.1016\/j.vaccine.2009.08.102_bib21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/IAI.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/hv.1.4.1989","article-title":"Investigation in a model system of the effects of combinations of anthrax and pertussis vaccines administered to service personnel in the 1991 Gulf War","volume":"1","author":"Rijpkema","year":"2005","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib23","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2003.12.020","article-title":"CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques","volume":"22","author":"Klinman","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.vaccine.2006.07.056","article-title":"Increased potency of BioThrax\u00ae anthrax vaccine with the addition of C-class CpG oligonucleotide adjuvant CPG 10109","volume":"25","author":"Gu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib25","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.micinf.2007.08.002","article-title":"Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax","volume":"9","author":"Klinman","year":"2007","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2009.08.102_bib26","series-title":"45th annual ICACC meeting","article-title":"Marked enhancement of antibody response to anthrax vaccine adsorbed with CPG 7909 in healthy volunteers","author":"Rynkiewicz","year":"2005"},{"key":"10.1016\/j.vaccine.2009.08.102_bib27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib28","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial","volume":"24","author":"Gorse","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.3.5.4459","article-title":"Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults","volume":"3","author":"Campbell","year":"2007","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib30","series-title":"46th annual ICAAC meeting","article-title":"An ascending dose study to assess the safety and tolerability of an rPA anthrax vaccine, and compare its immunogenicity with that of Anthrax Vaccine Adsorbed (AVA)","author":"Dyson","year":"2006"},{"key":"10.1016\/j.vaccine.2009.08.102_bib31","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib32","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1016\/j.vaccine.2008.08.031","article-title":"Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induces protective immunity against Bacillus anthracis","volume":"26","author":"Yin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib33","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.vaccine.2003.11.064","article-title":"Pluronic\u00ae F127-based systemic vaccine delivery systems","volume":"22","author":"Coeshott","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib34","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s12272-001-2121-2","article-title":"Enhancement of the immune response of mice to Bacillus anthracis protective antigen by CIA07 combined with alum","volume":"31","author":"Kim","year":"2008","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.vaccine.2009.08.102_bib35","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1016\/j.vaccine.2009.03.069","article-title":"The mast cell activator compound 48\/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen","volume":"27","author":"McGowen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molimm.2006.02.032","article-title":"Low doses of antigen coupled to anti-CR2 mAbs induce rapid and enduring IgG immune responses in mice and in cynomolgus monkeys","volume":"44","author":"Whipple","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib37","doi-asserted-by":"crossref","first-page":"e1044","DOI":"10.1371\/journal.pone.0001044","article-title":"Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response","volume":"10","author":"Kolla","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2009.08.102_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.vaccine.2005.08.065","article-title":"Evidence for adjuvanticity of anthrax edema toxin","volume":"24","author":"Quesnel-Hellmann","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1099\/00221287-31-2-329","article-title":"The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymic activity","volume":"31","author":"Stanley","year":"1963","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4049\/jimmunol.96.4.727","article-title":"Immunologic studies of anthrax. IV. Evaluation of the immunogenicity of three components of anthrax toxin","volume":"96","author":"Mahlandt","year":"1966","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/IAI.52.2.509-512.1986","article-title":"Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig","volume":"52","author":"Little","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib42","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"Hermanson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.08.102_bib43","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.vaccine.2005.08.056","article-title":"N-fragment of edema factor as a candidate antigen for immunization against anthrax","volume":"24","author":"Zeng","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib44","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/IAI.66.7.3447-3448.1998","article-title":"Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis","volume":"66","author":"Singh","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0006-291X(03)01227-0","article-title":"Deletion mutants of protective antigen that inhibit anthrax toxin both in vitro and in vivo","volume":"307","author":"Ahuja","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.femsim.2005.05.009","article-title":"Efficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracis","volume":"45","author":"Rhie","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib47","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/CVI.00402-07","article-title":"Detoxified lethal toxin as a potential mucosal vaccine against anthrax","volume":"15","author":"Xu","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib48","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.vaccine.2007.11.087","article-title":"Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates","volume":"26","author":"Yan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2004.05.029","article-title":"Anthrax capsule vaccine protects against experimental infection","volume":"23","author":"Chabot","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib50","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1074\/jbc.M509432200","article-title":"Immunogenicity and protective efficacy of Bacillus anthracis poly-g-d-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy","volume":"281","author":"Joyce","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.08.102_bib51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/IAI.70.2.661-664.2002","article-title":"Anthrax spores make an essential contribution to vaccine efficacy","volume":"70","author":"Brossier","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib52","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1128\/IAI.00884-07","article-title":"Recombinant exosoporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen","volume":"75","author":"Brahmbhatt","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib53","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1016\/j.vaccine.2008.07.015","article-title":"Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen","volume":"26","author":"Cybulski","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib54","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1016\/j.vaccine.2005.08.031","article-title":"DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components","volume":"24","author":"Hahn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib55","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/S0264-410X(02)00207-4","article-title":"Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin","volume":"20","author":"Gaur","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib56","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib57","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1086\/426865","article-title":"Protective immunization against inhalational anthrax: A comparison of minimally invasive delivery platforms","volume":"191","author":"Mikszta","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.08.102_bib58","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11095-005-9078-7","article-title":"Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine-DNA particles","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.102_bib60","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11095-006-0206-9","article-title":"Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2009.08.102_bib61","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/IAI.00070-07","article-title":"Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against B. anthracis spore challenge","author":"Bielinska","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib62","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4161\/hv.3.3.4011","article-title":"Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge","volume":"3","author":"Huang","year":"2007","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib63","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.vaccine.2006.02.024","article-title":"An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits","volume":"24","author":"Wimer-Mackin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib64","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/IAI.72.2.1181-1183.2004","article-title":"Needle-free skin patch vaccination method for anthrax","volume":"72","author":"Matyas","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib65","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/422694","article-title":"Induction of protective immunity against lethal anthrax challenge with a patch","volume":"190","author":"Kenney","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.08.102_bib66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0264-410X(94)90223-2","article-title":"Human live anthrax vaccine in the former USSR","volume":"12","author":"Shlyakhov","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib67","first-page":"104","article-title":"Progress in the control and research of anthrax in China","volume":"68","author":"Dong","year":"1990","journal-title":"Salis Med Bull"},{"key":"10.1016\/j.vaccine.2009.08.102_bib68","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1128\/IAI.67.2.562-567.1999","article-title":"Vaccination against anthrax with attenutated recombinant strains of Bacillus anthracis that produce protective antigen","volume":"67","author":"Barnard","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib69","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1016\/j.vaccine.2004.11.077","article-title":"Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components","volume":"23","author":"Mendelson","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib70","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/IAI.00530-08","article-title":"Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax","volume":"77","author":"Skoble","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.58.2.303-308.1990","article-title":"Immunization against anthrax with aromatic compound-dependent (Aro\u2212) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen","volume":"58","author":"Ivins","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib72","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.vaccine.2006.07.037","article-title":"Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen","volume":"25","author":"Duc","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib73","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/IAI.01242-06","article-title":"Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis","volume":"75","author":"Stokes","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib74","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/IAI.00828-08","article-title":"Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge","volume":"77","author":"Osorio","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib75","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1073\/pnas.0900029106","article-title":"Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge","volume":"106","author":"Mohamadzadeh","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.08.102_bib76","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/IAI.59.6.1961-1965.1991","article-title":"Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals","volume":"59","author":"Iacono-Connors","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib77","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.71.3.1491-1496.2003","article-title":"Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge","volume":"71","author":"Lee","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.102_bib78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.mt.6300034","article-title":"Adenovirus-based prime-boost immunization for rapid vaccination against anthrax","volume":"15","author":"McConnell","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2009.08.102_bib79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/eji.200838058","article-title":"Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses","volume":"39","author":"Midha","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijmm.2003.12.002","article-title":"Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination","volume":"294","author":"Hahn","year":"2004","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.102_bib81","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.102_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/hv.5.8.8725","article-title":"Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults","volume":"5","author":"Keitel","year":"2009","journal-title":"Hum Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T06:22:01Z","timestamp":1685168521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09013127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":82,"alternative-id":["S0264410X09013127"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.102","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}